Bate Kenneth
SEC-identified person · CIK 1210238 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Catabasis Pharmaceuticals INC CATB | Director | filed 2015 - 2026 |
| Synta Pharmaceuticals Corp SNTA | Director | filed 2016 - 2025 |
| Aveo Pharmaceuticals, INC. AVEO | Director | filed 2010 - 2023 |
| Epizyme, Inc. EPZM | Director | filed 2014 - 2022 |
| Genocea Biosciences, INC. GNCA | Director | filed 2014 - 2021 |
| Vanda Pharmaceuticals Inc. VNDA | Director | filed 2015 - 2017 |
| Biomarin Pharmaceutical INC BMRN | Director | filed 2010 - 2015 |
| Cubist Pharmaceuticals INC cbst | Director | filed 2006 - 2015 |
| Nitromed INC NTMD | Director · President & CEO | filed 2006 - 2009 |
| Coley Pharmaceutical Group, Inc. COLY | Director | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.